GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Provides longer GLP-1 receptor activation. Depending on the medication, the effects can last for a minimum of 24 hours to a ...

Compounded GLP-1 medications are typically safe for most people. But since compounded GLP-1s aren’t FDA-approved, the FDA ...

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role ...

Glucagon-like peptide 1 (GLP-1) receptor agonist medications have revolutionized obesity medicine. But they’re not without problems. In the early days of the social media craze, news reports ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

In part 1 of the so-called ESSENCE trial, treatment with the GLP-1 receptor agonist resulted in higher week-72 rates of steatohepatitis resolution without worsening of liver fibrosis (63% vs 34% ...

Lentils are full of fiber, which “slows down digestion,” once again reproducing the effect of the GLP-1 drugs, at a cost of ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Related Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction Weight-loss drugs can help stroke survivors prevent recurrence Weight-loss surgeries decline 25% as GLP-1 drugs ...